Brentuximab Vedotin (Adcetris®) for the Treatment of CD30-Positive Hematologic Malignancies

Niels W.C.J. Van De Donk, Eugen Dhimolea

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Fingerprint

Dive into the research topics of 'Brentuximab Vedotin (Adcetris®) for the Treatment of CD30-Positive Hematologic Malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds